Pierre-Alexandre Just - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pierre-Alexandre Just

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Nature Communications|July 16, 2024

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.

Nature Communications|August 26, 2025

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trialFlorence Joly, Alexandra Leary, Isabelle Ray-Coquard, et al.

Cell Reports. Medicine|December 20, 2023

GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profilesChristian Pozzorini, Gregoire Andre, Tommaso Coletta, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Nature Communications|July 16, 2024

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.

Nature Communications|August 26, 2025

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trialFlorence Joly, Alexandra Leary, Isabelle Ray-Coquard, et al.

Cell Reports. Medicine|December 20, 2023

GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profilesChristian Pozzorini, Gregoire Andre, Tommaso Coletta, et al.

Pageof 8